SCHEMBL15029191

SCHEMBL15029191

Cc1cccc(-c2c[nH]c(-c3ccccc3)n2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.47
METAP2 P50579 1/20 0.47
RAB9A P51151 6/20 0.47
NPC1 O15118 5/20 0.47
XDH P47989 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
TSHR P16473 2/20 0.45
HPGD P15428 1/20 0.45
KMO O15229 2/20 0.44
ALDH1A1 P00352 2/20 0.44
PIN1 Q13526 1/20 0.44
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
NR1I3 Q14994 1/20 0.43
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
CASP3 P42574 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17280159 0.90 ADORA2A (0.41) IDO1METAP2RAB9ANPC1SMN1; SMN2
SCHEMBL17279780 0.87 MEN1 (0.43) RAB9ANPC1SMN1; SMN2TSHRHPGD
SCHEMBL28147150 0.86 MAPT (0.42) RAB9ANPC1TSHRHPGDALDH1A1
SCHEMBL29662878 0.86 MAPK14 (0.53) IDO1METAP2RAB9ANPC1XDH
SCHEMBL26467067 0.85 ACHE (0.48) IDO1METAP2RAB9ANPC1XDH
SCHEMBL31659868 0.85 ACHE (0.48) IDO1METAP2RAB9ANPC1XDH
SCHEMBL17280165 0.84 NR1H2 (0.44) IDO1METAP2RAB9ANPC1SMN1; SMN2
SCHEMBL7144815 0.84 NR1H2 (0.51) RAB9ANPC1SMN1; SMN2TSHRHPGD
SCHEMBL7144979 0.84 NR1H2 (0.51) RAB9ANPC1SMN1; SMN2TSHRHPGD
SCHEMBL528246 0.83 MEN1 (0.46) IDO1METAP2RAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846948-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-09-30 US disclosed
US-8796467-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-08-05 US disclosed
US-20130150355-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-13 US disclosed
US-20130150347-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130150347-A1 NOVEL COMPOUNDS GRM5, GRM1, GRIK5 IDO1 3659/4885METAP2 3886/4885RAB9A 732/4885
US-20130150355-A1 NOVEL COMPOUNDS GRM5, GRIN2A, GRIN1 IDO1 3418/4885METAP2 4058/4885RAB9A 669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.